MedTrace Logo

Total Intravenous Anesthesia With Remifentanil-propofol Admixture

NCT04394897 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2020-05-20

No results posted yet for this study

Summary

Background: Application of total intravenous anesthesia (TIVA) may be considered as unpractical when compared with inhalational anesthesia. Although it is mostly not recommended, mixing intravenous agents seems to be popular in clinical practice. The aim of the study was to investigate the possible clinical drawbacks of using remifentanil-propofol admixture (MIXTIVA) for TIVA.

Conditions

  • Total Intravenous Anesthesia
  • Propofol
  • Remifentanil
  • Bispectral Index Monitoring

Interventions

COMBINATION_PRODUCT

Remifentanil-Propofol admixture

Sponsors & Collaborators

  • Bezmialem Vakif University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-12
Primary Completion
2014-04-12
Completion
2014-04-12

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04394897 on ClinicalTrials.gov